Navigation Links
Leading Health Economist, Dr. Hong Wang, Joins Abt Associates

Expert in International Health Economics and Financing and Health Policy

Will Play Leading Role in Health Systems 20/20 Project

CAMBRIDGE, Mass., July 14 /PRNewswire/ -- Abt Associates announced that Dr. Hong Wang, M.D., Ph.D., has joined the company as a Senior Health Economist working primarily on the Health Systems 20/20 project, which is the USAID Bureau of Global Health's Principal Project for Health System Strengthening.

His responsibilities will include overseeing and guiding the health financing and economics activities of the project; leading the strategic technical assistance and applied research assignments; representing the project in meetings and public forums on financing and economics issues and topics; and ensuring the quality of the project's health financing related work.

Dr. Wang, most recently a faculty member at Yale University, has more than 20 years experience in research, teaching, and consulting in health policy internationally. Dr. Wang received his M.D. from Beijing Medical University, and his Ph.D. in Population Health from the University of Wisconsin-Madison. In the U.S., he has also been a Takemi Fellow in International Health at the Harvard School of Public Health in Cambridge, MA, and a Visiting Scholar in Health Economics and Health Management at the University of Wisconsin-Madison. In China he was deputy director of both the National Health Economic Institute of the Ministry of Health in Beijing, and the Department of Health Economics at Beijing Medical University. Dr. Wang has a solid and extensive research background and has conducted studies and authored numerous publications on health policy issues particularly in the realm of rural community health initiatives, health insurance reforms, and health financing and payment schemes.

"Dr. Hong Wang is a fabulous addition to our staff and to the Health Systems 20/20 team," said Tessie San Martin, Group Vice President for International Development at the company. "His more than 20 years of experience in research, teaching, and consulting in health policy internationally, and his very practical experience as deputy director of both the National Health Economic Institute of the Ministry of Health in Beijing, and the Department of Health Economics at Beijing Medical University, provide him with a very rich perspective which will be invaluable to our clients."

In addition to his work as a professor and researcher, Dr. Wang has ample experience as a consultant in leading program design, implementation, and evaluation for international health projects for a variety of different organizations and contexts. He worked with the Chinese government in developing the Rural Health Improvement Program as part of the VIII World Bank Health Loan Projects in China, participated in a Harvard-led social experiment on community-based health care financing schemes in rural China, served as a consultant for the Clinton foundation to lead the development and implementation of a provider payment system to improve the efficiency and quality of HIV/AIDS patient treatment in China, and also developed human resources programs for initiatives organized by the World Bank in Mozambique, Zambia, and Lesotho. Dr. Wang also has experience with health sector capacity-building in developing countries and has served as a key trainer for the World Bank Flagship Workshop on health system reform in China, and as the coordinator for the Network of Training and Research in Health Economics & Financing, an initiative sponsored by the World Bank and the MOH in China.

Dr. Wang is a member of the Global Health Workforce Alliance, the Science Committee for IHEA, and the Chinese MOH Advisory Committee of Health Policy. He is also a Program Officer for the Milbank Memorial Fund. He has published more than 30 articles in peer-reviewed journals and co-authored six books.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.

SOURCE Abt Associates
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Europes leading pharmacologists to meet in Manchester
2. CPC Hand-Delivers Patient Testimonies to State Leaders Pleading for No Budget Cuts to Health and Human Services
3. U.S. Preventive Medicine Applauds Leading Health Organizations for Disease Prevention Platforms
4. Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery
5. Leading worldwide cause of cardiovascular disease may be modified by diet
6. Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet
7. Leading Vaccine Expert Joins IAVI
8. Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
9. Chinas Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
10. Leading Provider of Electronic Medical Records (EMR) Systems for Sleep Centers Adds Field Sales Representative
11. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
Post Your Comments:
(Date:11/30/2015)... Minneapolis, MN (PRWEB) , ... December 01, 2015 ... ... Nationwide® is the latest carrier to offer individual vision insurance plans on ... with the unique ability to rate and review products, allowing consumers to compare, ...
(Date:11/30/2015)... Louis, MO (PRWEB) , ... November 30, 2015 , ... ... and exclusion criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One ... for Disease Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Stress, anxiety, illness, infection or ... worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon at Joe ... some signs might point to tumors. , “Bad headaches that don’t go ...
(Date:11/30/2015)... ... 2015 , ... Thermi™, a world leader in thermistor-regulated energy ... temperature controlled radiofrequency platform has received CE marking and may now be sold ... as a clinical endpoint. The technology has been available in the United ...
(Date:11/30/2015)... ... 2015 , ... MOSI recently added two state-of-the-art augmented reality (AR) experiences from ... to their collection of interactive exhibits within the Kids In Charge! building. In collaboration ... to get closer than ever to a range of animals as they drink, sleep ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 2015 MEDTEC Japon 2016, ... d,Asie portant sur la conception de ... se tiendra à Tokyo ... avril 2016. ... - Logo - ...
(Date:11/30/2015)... TOKYO , Nov. 30, 2015 MEDTEC Japan 2016, ... and Manufacturing industry, is to be held in Tokyo from 20 th  - 22 ... --> -->   --> ...   the United States . With the aging population ... markets continuing to grow steadily. --> the United States ...
(Date:11/30/2015)... -- QT Vascular Ltd., together with its subsidiaries (the "Company" ... Medical LLC and Quattro Vascular Pte. Ltd., collectively the ... and distribution of advanced therapeutic solutions for the minimally ... that a three-judge panel of the United ... Circuit ("Federal Circuit") has unanimously granted the Group and ...
Breaking Medicine Technology: